Health IT Analytics May 16, 2018
The Harvard Business School Kraft Precision Medicine Accelerator will bring together five cancer organizations to share research best practices and engage patients.
The Harvard Business School Kraft Precision Medicine Accelerator has announced that five leading cancer organizations will come together to share best practices, engage patients, and create synergies to advance precision medicine across cancers.
The organizations include the LUNGevity Foundation, the Metastatic Breast Cancer Alliance, the Multiple Myeloma Research Foundation (MMRF), the Pancreatic Cancer Action Network (PanCAN), and the Prostate Cancer Foundation.
The Kraft Precision Medicine Accelerator, an initiative that uses collective impact to advance precision medicine, convenes best-in-class healthcare leaders and stakeholders to develop a business framework that will accelerate innovations personalized medicine.
Today's Sponsors
Today's Sponsor